# Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

> **NCT00620698** · — · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 89 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00620698
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-03
- **Final completion:** 2012-03
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2014-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00620698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00620698, "Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00620698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*